Warning! GuruFocus detected
5 Severe warning signs
with PIQ.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Proteomics International Laboratories Ltd
ISIN : AU000000PIQ0
Description
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.48 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 15.52 | |||||
| Beneish M-Score | -4.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -18.6 | |||||
| 3-Year EBITDA Growth Rate | -40.8 | |||||
| 3-Year EPS without NRI Growth Rate | -22.1 | |||||
| 3-Year FCF Growth Rate | -26 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 41.72 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 119.64 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.05 | |||||
| 9-Day RSI | 21.18 | |||||
| 14-Day RSI | 26.46 | |||||
| 3-1 Month Momentum % | -36.73 | |||||
| 6-1 Month Momentum % | -29.55 | |||||
| 12-1 Month Momentum % | -60.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | |||||
| Quick Ratio | 4.7 | |||||
| Cash Ratio | 4.43 | |||||
| Days Sales Outstanding | 68.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | -0.41 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1106.87 | |||||
| Net Margin % | -793.8 | |||||
| FCF Margin % | -610.19 | |||||
| ROE % | -106.34 | |||||
| ROA % | -86.56 | |||||
| ROIC % | -392.68 | |||||
| 3-Year ROIIC % | -467.31 | |||||
| ROC (Joel Greenblatt) % | -442.01 | |||||
| ROCE % | -134.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 60 | |||||
| PB Ratio | 10 | |||||
| Price-to-Tangible-Book | 10.13 | |||||
| EV-to-EBIT | -5.14 | |||||
| EV-to-EBITDA | -5.58 | |||||
| EV-to-Revenue | 55.11 | |||||
| EV-to-FCF | -9.03 | |||||
| Price-to-GF-Value | 0.83 | |||||
| Price-to-Net-Current-Asset-Value | 13.5 | |||||
| Price-to-Net-Cash | 13.5 | |||||
| Earnings Yield (Greenblatt) % | -19.46 | |||||
| FCF Yield % | -10.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Proteomics International Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.903 | ||
| EPS (TTM) (A$) | -0.055 | ||
| Beta | -0.32 | ||
| 3-Year Sharpe Ratio | -0.7 | ||
| 3-Year Sortino Ratio | -0.92 | ||
| Volatility % | 36.91 | ||
| 14-Day RSI | 26.46 | ||
| 14-Day ATR (A$) | 0.028476 | ||
| 20-Day SMA (A$) | 0.48425 | ||
| 12-1 Month Momentum % | -60.59 | ||
| 52-Week Range (A$) | 0.365 - 1.295 | ||
| Shares Outstanding (Mil) | 131 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Proteomics International Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Proteomics International Laboratories Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Proteomics International Laboratories Ltd Frequently Asked Questions
What is Proteomics International Laboratories Ltd(ASX:PIQ)'s stock price today?
The current price of ASX:PIQ is A$0.41. The 52 week high of ASX:PIQ is A$1.30 and 52 week low is A$0.37.
When is next earnings date of Proteomics International Laboratories Ltd(ASX:PIQ)?
The next earnings date of Proteomics International Laboratories Ltd(ASX:PIQ) is .
Does Proteomics International Laboratories Ltd(ASX:PIQ) pay dividends? If so, how much?
Proteomics International Laboratories Ltd(ASX:PIQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers